Multidisciplinary Shared Decision Making of Fertility Preservation in Young Women With Breast Cancer

Launched by MEDICALEXCELLENCE · Nov 17, 2021

Keywords

ClinConnect Summary

This clinical trial, called MYBC, is focused on helping young women with breast cancer make informed decisions about preserving their fertility before starting treatment. It specifically aims to understand how a team of healthcare professionals can best support women aged 19 to 40 who have been diagnosed with breast cancer but do not have cancer that has spread to other parts of their body. The trial is looking for participants who have not yet undergone any treatments like chemotherapy or surgery and who can give their consent after understanding the study.

If you are a woman within this age range and have been diagnosed with breast cancer, you may be eligible to participate. During the trial, participants will receive guidance on their options for fertility preservation, which could be very important for their future family planning. It's important to note that this trial is not yet recruiting participants, but it aims to provide valuable insights into how young women can manage their health and fertility options while facing a breast cancer diagnosis.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Women aged 19 to 40 years old
• • A person diagnosed with breast cancer by biopsy
• • Those who don't have evidence of distant metastasis
• • Eastern Cooperative Oncology Group(ECOG) performance status: 0-2 score
• • Before registering for clinical trials, chemotherapy, radiation therapy, anti-hormone therapy, immunotherapy, and surgery are not performed
• • A person who has fully understood and listened to the explanation of this clinical trial and then gave written consent
• Exclusion Criteria:
• • Histologically, a person diagnosed with follicular or sarcoma
• • Those with a history of breast cancer (including recurrent breast cancer)
• • A person diagnosed with another cancer before breast cancer
• • A person diagnosed with metastatic breast cancer
• • A person who has a mental illness and has a hard time understanding clinical trials
• • Those who plan to conduct follow-up observation elsewhere(to change of hometowm)
• • Menopausal factors without menstruation after more than a year from the last menstrual date
• • A pregnant woman
• • Inappropriate for participation in clinical trials